Unknown PHASE2 INTERVENTIONAL 2-arm NCT00301483

A Single Site Safety and Tolerability Study of HBOC-201 in Trauma Subjects

A Single-Center, Study to Evaluate the Safety and Tolerability of Hemoglobin-Based Oxygen Carrier-201 (HBOC 201) in Trauma Subjects. (Phase II - Safety and Tolerability)

Sponsor: Biopure Corporation

Conditions Wounds and Injuries

Interventions Hemoglobin-based oxygen carrier-201 (HBOC 201) Standard of Care

Updated 5 times since 2017 Last updated: Mar 5, 2008 Started: Jul 31, 2004 Primary completion: Sep 30, 2008 Completion: Dec 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Wounds and Injuries, this trial is ongoing. The trial is conducted by Biopure Corporation and has accumulated 5 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Jul 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biopure Corporation

Data source: Biopure Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Johannesburg, South Africa